PERIOD.
STUART: ALL RIGHT, KEITH, WE WE
HEAR YOU.
THE MARKET HAS NOW OPENED ON
THIS MONDAY MORNING.
WE’VE OPENED TO THE UP SIDE
RIGHT FROM THE GET GO HERE.
WE’VE GOT THE DOW 30 ON YOUR
SCREENS, AND THEY’RE ALL EXCEPT
FOR AMGEN, MERCK, INTEL INTEL
AND NIKE.
THE REST OF THEM ARE UP TODAY.
IT’S A STRONG MARKET OPEN.
DOW’S UP 164, EXACTLY A HALF
PERCENTAGE POINT.
S&P 500 UP .4%, PRETTY SOLID,
AND THE NASDAQ COMPOSITE IS UP
ONE-THIRD OF 1%.
BIG TECH, WE’LL SHOW YOU THESE
RIGHT AT THE OPENING BELL
BECAUSE THIS IS WHERE THE MONEY
IS AND SOMETIMES THE MOMENTUM
IS.
EVERYTHING’S UP EXCEPT MICROSOFT
WHICH IS UNCHANGED AT THIS
POINT, AND NOW IT’S EVER SO
SLIGHTLY LOWER.
HOW ABOUT TESLA?
I THINK TESLA’S UP THIS MORNING,
YES, IT IS, A GAIN OF NEARLY 2%.
ALL RIGHT, LAUREN, WHAT IS THIS
ABOUT A $5 BILLION DEAL FOR
NICKEL?
LAUREN: WELL, THEY’RE GOING TO
NEED MORE BATTERIES, AND REPORTS
SAY THEY SIGNED CONTRACTS WORTH
ABOUT $5 BILLION FROM THE IF
COUNTRY OF INDONESIA TO SUPPLY
THEM WITH NICKEL.
LOOK, THE INFLATION REDUCTION
ACT BENEFITS TESLA, MGM MORE
THAN THE OTHER AUTOMAKERS.
YOU’RE GETTING A $7500 EV
CREDIT, SO THAT’S ANOTHER REASON
THE STOCK IS UP 2.5%.
STUART: SIGNIFY HEALTH POSSIBLY
TO BE BOUGHT BY CVS, SIGNIFY
HEALTH UP 15.
LAUREN: YEP.
CVS IS LOOKING TO EXPAND IN THE
IN-HOME HEALTH SERVICES CATEGORY
ACCORDING TO "THE WALL STREET
JOURNAL," SO THAT’S WHY THEY
WOULD WANT SIGNIFY HEALTH.
AMAZON WENT IN AND BOUGHT ONE
MEDICAL, SO THEY’RE LOOKING FOR
SOMEONE TO EXPAND THAT PART OF
THE SERVICES.
M&A MONDAY ESPECIALLY IN HEALTH CARE, BECAUSE PFIZER IS SPENDING
CARE, BECAUSE PFIZER IS SPENDING
NORTH OF $5 MILLION ON A BLOOD
MAKER.
NOW YOU HAVE MARKETS COMING UP
AND COMPANIES SAYING, OKAY,
LET’S MAKE SOME DEALS.
STUART: FIND ME A TARGET, LET ME
BUY INTO THE TARGET AND SEE THE
PRICE GO UP.
IF ONLY YOU COULD PREDICT WHO
THE TARGET IS GOING TO BE.
CARAVAN THAT.
I KNOW THE STOCK IS UP 110% JUST
IN A QUARTER.
LAUREN: YEP.
STUART: BUT I’VE BEEN READING
THAT JPMORGAN, THEY’RE OFFERING
A WARNING, AND YET THE STOCK IS
UP THIS MORNING. LAUREN: THE FACT THAT IT’S UP
LAUREN: THE FACT THAT IT’S UP
ANOTHER 1%, HE WERE UP 40% ON
FRIDAY.
THEY SAY THEY’RE EXPENSIVE
COMPARED TO SOME OF THEIR PEERS,
BUT THEN THEY RAISED THE PRICE
TARGET BY $10 TO 35.
THEY SAY, LOOK, THERE ARE ALL
THESE INVESTMENTS THAT CARAVAN
THAT’S MAKING IN INFRASTRUCTURE
AND NETWORKING COULD GIVE IT A
LONG-TERM COMPETITIVE ADVANTAGE
BUT NOT RIGHT NOW.
THEY DOWNGRADED THEM AND RAISED
THE PRICE TARGET.
STUART: JUST MOMENTS AGO, BY THE
WAY, THE DOW CROSSED 33,000
AGAIN.
HOW ABOUT THAT?
PALANTIR, THAT’S A BIG DECLINE,
7%.
LAUREN: LOOK, THEY’RE NOT GOING
TO MAKE MONEY UNTIL 2025.
THE CEO SAYS WE WON’T BE
PROFITABLE MILLION THAT YEAR.
THEY CUT THEIR FORECAST.
THEY REPORTED A SURPRISE LOSS.
THEY DO A LOT OF BUSINESS WITH
WITH THE U.S. GOVERNMENT, BUT
THE TIMING OF SOME OF THOSE
CONTRACTS, UNCERTAIN FOR THEM.
I THOUGHT THAT WAS INTERESTING
BECAUSE THE COMMERCIAL SIDE OF
THEIR BUSINESS IS BOOMING, AND
THEY ALSO DO BUSINESS WITH THE
E.U. NOW, YOU KNOW, RUSSIA AND
UKRAINE.
BUT IT’S THE CONTRACT NEWS AND
THE NOT PROFITABLE FOR THE NEXT
COUPLE OF YEARS NEWS THAT’S
REALLY HAMMERING THE STOCK.
STUART: GETS YOU EVERY TIME.
THE CEO SAYS, WELL, WE’RE NOT
GOING TO MAKE PROFIT FOR A
COUPLE OF YEARS, DOESN’T LOOK
GOOD.
TYSON, WE HEARD JUST A FEW
MOMENTS AGO IN THAT KEITH FIFTHS
LIKES THEIR LONG-TERM -- FITZ
LIKES THEIR LORM PROSPECTS.
LAUREN: THE SILVER LINING IS
DEMAND FOR BEEF.
CHICKEN VOLUMES SELL.
HAVE YOU EVER BOUGHT A PREPARED
FOOD IN THE STORE?
IF IT IS SO EXPENSIVE.
THEY PRESEASON THE MEAT FOR YOU.
HEIR NOT DOING WELL THERE.
YOU’RE NOT GOING TO BUY THAT,
YOU CAN BUTT ADONE -- PUT ADOBE
ON YOUR OWN MEAT.
STUART: YOU’RE RIGHT.
I’VE LOST TRACK OF VACCINE
STOCKS, BUT I UNDERSTAND WE’VE
GOT BIONTECH WORKING ON TWO FEW
VACCINES AND THE STOCK DOWN
NEARLY 10%.
I CAN’T WORK THE VACCINE MARKET
OUT, I REALLY CAN’T.
LAUREN: IF YOU ASKED A RELL
PERSON, ARE YOU GOING TO GET A
BOOSTER SHOT, THEY SAY, WELL,
WILL LEAPT ME SEE WHAT THE NEXT
VARIANT IS.
IF IT’S BAD, MAYBE.
THERE ARE TWO OMICRON-ADAPTED
VACCINES THAT BIONTECH IS
WORKING ON, AND THEY SAY HALE BE
AVAILABLE IN OCTOBER -- THEY’LL
BE AVAILABLE IN OCTOBER.
BUT DEMAND HAS OBVIOUSLY BEEN
COMING DOWN CAN, AND SO IS THE
STOCK.
IT’S DOWN 9% AT MOMENT.
STUART: WHETHER YOU CAN PROVE IT
OR NOT, IT’S ONLY ANECDOTAL THAT
PEOPLE ARE NOT GETTING TESTED,
THEY’RE NOT GETTING BOOSTER
SHOTS AND THE NEW VACCINE.
LAUREN: AND THE PROFIT AND THE
REVENUE FOR BIONTECH BOTH FELL.
SO LOOKING FORWARD, NO ONE’S
CONVINCED ABOUT THESE TWO
OMICRON VACCINES.
STUART: IT’S BEEN A PRETTY GOOD
MONDAY MORNING SO FAR.
WE’VE ONLY BEEN IN BUSINESS ON
WALL STREET FOR 5 MINUTES, BUT
LOOK AT THAT, WE’LL TAKE IT.
THE DOW THE’S UP 200, JUST OVER
TWO-THIRDS OF 1%.
WHO ARE THE DOWN LEADERS?
BOEING -- DOW LEADERS?
BOEING, AMERICAN EXPRESS, HOME
DEPOT, DISNEY.
WE’VE GOT A REPORT COMING UP ON
THEM.
ALL OF THEM HIGHER THIS MORNING.
S&P 500 WINNERS, GAP, GOT THEM.
FREEPORT-McMORAN ENERGY,
NORWEGIAN CRUISE LINES IS BACK
IN THERE AGAIN.
AND NASDAQ WINNERS, TESLA RIGHT
UP TOP, OKTA, eBay AND
PAYPAL COMING BACK.
>>> THE 10-YEAR TREASURY YIELD,
WHERE’S THAT?
EARLIER IT WAS AT 2.80%, NOW IT
DROPPED TO 2.79.
THE PRICE OF GOLD, HAS IT
REACHED $1800 YET?
NOT QUITE, 1798.
BITCOIN STILL ABOVE $24,000 A
COIN.
OIL BELOW $90 A BARREL, 88.78 TO
BE PRECISE.
NAT GAS IS DOWN QUITE
SIGNIFICANTLY, 5% THIS MORNING.
AVERAGE PRICE FOR A GALLON OF
GAS GETTING AWFULLY CLOSE TO $4
PER GALLON NATIONWIDE.
IT’S ACTUALLY $4.05 RIGHT NOW.